FDA advisory panel unanimously recommends Moderna Covid booster shots for at-risk adults

FDA panel unanimously recommends Moderna Covid booster shots for at-risk adults The endorsement is a crucial step before the U.S. can start giving third shots to some of the millions of Americans who originally received Moderna's vaccine. Berkeley Lovelace Jr. CNBC

A key Food and Drug Administration advisory committee unanimously recommended Thursday giving booster shots of Moderna’s Covid-19 vaccine to people age 65 and older and other vulnerable Americans, a crucial step before the U.S. can start administering third shots to some of the more than 69 million people who originally received that vaccine.

The nonbinding decision by the FDA’s Vaccines and Related Biological Products Advisory Committee would bring guidelines for Moderna in line with third shots of Pfizer and BioNTech’s vaccine. Those shots were authorized less than a month ago to a wide array of Americans, including the elderly, adults with underlying medical conditions and those who work or live in high-risk settings like health and grocery workers.

While the agency hasn’t always followed the advice of its committee, it often does. A final FDA decision on Moderna boosters could come within days ...

ALSO SEE: Moderna has become the world's vaccine boogeyman for not doing enough for poor countries.